It is interesting to look at the expression of DNA-PK, MYT1L, and CXCR1 and the levels of phosphorylated ERK1/2 in a large cohort of glioblastoma tissue samples and correlate the levels of these molecules to clinicopathological parameters of this disease. The gene discussed is CXCR1; the disease is glioblastoma.